Literature DB >> 2410927

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

T Hirano, T Taga, N Nakano, K Yasukawa, S Kashiwamura, K Shimizu, K Nakajima, K H Pyun, T Kishimoto.   

Abstract

Human B-cell differentiation factor (BCDF) was purified to homogeneity by sequential filtration and chromatography of culture supernatants from TCL-Na1 cells on an AcA34 gel column and then on a Mono P column with fast protein liquid chromatography and reversed-phase HPLC. A 5300-fold enrichment in specific activity of BCDF with about 25% recovery was attained. The homogeneity of purified BCDF was evidenced by the following: (i) the specific activity was 1.7 X 10(7) units/mg of protein, (ii) only two bands, Mr 19,000 and 21,000, were identified by NaDodSO4/PAGE under reduced as well as nonreduced conditions, and (iii) BCDF activity was recovered from the gel after NaDodSO4/PAGE in the fractions corresponding to protein bands of Mr 19,000 or 21,000. Purified BCDF induced Ig secretion in Epstein-Barr virus-transformed cell lines; as little as 3 pM gave 50% of the maximum reaction achieved by 30-80 pM BCDF. Purified BCDF induced Ig production in activated B cells without any effect on cell growth. Purified BCDF did not show any activity of interleukin 1 or 2, B-cell stimulatory factor (BSF)p-1, B-cell growth factor II (BCGF-II), or interferon. Since BCDF was isolated and characterized as described, we propose that the BCDF that induces the final differentiation of B cells into high-rate Ig-secreting cells be designated BSFp-2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410927      PMCID: PMC391148          DOI: 10.1073/pnas.82.16.5490

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  A convenient and rapid cytopathic effect inhibition assay for interferon.

Authors:  P C Familletti; S Rubinstein; S Pestka
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line.

Authors:  E Puré; P C Isakson; K Takatsu; T Hamaoka; S L Swain; R W Dutton; G Dennert; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

4.  A highly sensitive enzyme-linked immunosorbent assay for human immunoglobulin E: comparison of microtiter plate and disk methodologies.

Authors:  P K Goldsmith
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

5.  T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF.

Authors:  A Muraguchi; T Kishimoto; Y Miki; T Kuritani; T Kaieda; K Yoshizaki; Y Yamamura
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.

Authors:  K Yoshizaki; T Nakagawa; T Kaieda; A Muraguchi; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

7.  Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I).

Authors:  T Hirano; T Teranishi; K Onoue
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

8.  Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.

Authors:  K Takatsu; K Tanaka; A Tominaga; Y Kumahara; T Hamaoka
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

9.  Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen.

Authors:  S L Swain; G Dennert; J F Warner; R W Dutton
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.

Authors:  H J Leibson; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  156 in total

1.  Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity.

Authors:  F Makishima; S Terada; T Mikami; E Suzuki
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 2.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

3.  Plasma interleukin-6 levels in Mediterranean spotted fever.

Authors:  J Oristrell; M Sampere; M J Amengual; B Font; F Segura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-22       Impact factor: 3.267

4.  A novel cytokine-inducing glycolipid isolated from the lipoteichoic acid fraction of Enterococcus hirae ATCC 9790: a fundamental structure of the hydrophilic part.

Authors:  M Hashimoto; Y Imamura; J Yasuoka; S Kotani; S Kusumoto; Y Suda
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

5.  Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis.

Authors:  N Miyasaka; K Sato; Y Kitano; M Higaki; K Nishioka; K Ohta
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

6.  Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6.

Authors:  D Habetswallner; E Pelosi; D Bulgarini; A Camagna; P Samoggia; E Montesoro; G Giannella; D Lazzaro; G Isacchi; U Testa
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

7.  Human natural killer (NK) cells produce a late-acting B-cell differentiation activity.

Authors:  H Kimata; E H Sherr; A Saxon
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

Review 8.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

9.  Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611.

Authors:  K Matsushita; S Nagaoka; R Arakaki; Y Kawabata; K Iki; M Kawagoe; H Takada
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities.

Authors:  H Takada; Y Kawabata; R Arakaki; S Kusumoto; K Fukase; Y Suda; T Yoshimura; S Kokeguchi; K Kato; T Komuro
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.